These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31744836)

  • 1. CX3CR1-fractalkine axis drives kinetic changes of monocytes in fibrotic interstitial lung diseases.
    Greiffo FR; Viteri-Alvarez V; Frankenberger M; Dietel D; Ortega-Gomez A; Lee JS; Hilgendorff A; Behr J; Soehnlein O; Eickelberg O; Fernandez IE
    Eur Respir J; 2020 Feb; 55(2):. PubMed ID: 31744836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented concentrations of CX3CL1 are associated with interstitial lung disease in systemic sclerosis.
    Hoffmann-Vold AM; Weigt SS; Palchevskiy V; Volkmann E; Saggar R; Li N; Midtvedt Ø; Lund MB; Garen T; Fishbein MC; Ardehali A; Ross DJ; Ueland T; Aukrust P; Lynch JP; Elashoff RM; Molberg Ø; Belperio JA
    PLoS One; 2018; 13(11):e0206545. PubMed ID: 30457999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions.
    Mikosz A; Ni K; Gally F; Pratte KA; Winfree S; Lin Q; Echelman I; Wetmore B; Cao D; Justice MJ; Sandhaus RA; Maier L; Strange C; Bowler RP; Petrache I; Serban KA
    Am J Physiol Lung Cell Mol Physiol; 2023 Dec; 325(6):L711-L725. PubMed ID: 37814796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles for the CX3CL1/CX3CR1 and CCL2/CCR2 Chemokine Systems in Hypoxic Pulmonary Hypertension.
    Amsellem V; Abid S; Poupel L; Parpaleix A; Rodero M; Gary-Bobo G; Latiri M; Dubois-Rande JL; Lipskaia L; Combadiere C; Adnot S
    Am J Respir Cell Mol Biol; 2017 May; 56(5):597-608. PubMed ID: 28125278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of circulating fractalkine (CX3CL1) and CX3CR1(+)CD4(+) T cells with common carotid artery intima-media thickness in patients with chronic kidney disease.
    Yadav AK; Lal A; Jha V
    J Atheroscler Thromb; 2011; 18(11):958-65. PubMed ID: 21873805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of platelet and monocyte function by the chemokine fractalkine (CX3 CL1) in cardiovascular disease.
    Flierl U; Bauersachs J; Schäfer A
    Eur J Clin Invest; 2015 Jun; 45(6):624-33. PubMed ID: 25832902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with an Anti-CX3CL1 Antibody Suppresses M1 Macrophage Infiltration in Interstitial Lung Disease in SKG Mice.
    Mizutani S; Nishio J; Kondo K; Motomura K; Yamada Z; Masuoka S; Yamada S; Muraoka S; Ishii N; Kuboi Y; Sendo S; Mikami T; Imai T; Nanki T
    Pharmaceuticals (Basel); 2021 May; 14(5):. PubMed ID: 34067842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CC chemokine MCP-1 stimulates surface expression of CX3CR1 and enhances the adhesion of monocytes to fractalkine/CX3CL1 via p38 MAPK.
    Green SR; Han KH; Chen Y; Almazan F; Charo IF; Miller YI; Quehenberger O
    J Immunol; 2006 Jun; 176(12):7412-20. PubMed ID: 16751386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractalkine promotes human monocyte survival via a reduction in oxidative stress.
    White GE; McNeill E; Channon KM; Greaves DR
    Arterioscler Thromb Vasc Biol; 2014 Dec; 34(12):2554-62. PubMed ID: 25359863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross talk between smooth muscle cells and monocytes/activated monocytes via CX3CL1/CX3CR1 axis augments expression of pro-atherogenic molecules.
    Butoi ED; Gan AM; Manduteanu I; Stan D; Calin M; Pirvulescu M; Koenen RR; Weber C; Simionescu M
    Biochim Biophys Acta; 2011 Dec; 1813(12):2026-35. PubMed ID: 21888931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrocyte measurement in peripheral blood correlates with number of cultured mature fibrocytes in vitro and is a potential biomarker for interstitial lung disease in Rheumatoid Arthritis.
    Just SA; Lindegaard H; Hejbøl EK; Davidsen JR; Bjerring N; Hansen SWK; Schrøder HD; Hansen IMJ; Barington T; Nielsen C
    Respir Res; 2017 Jul; 18(1):141. PubMed ID: 28720095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterisation of fractalkine/CX3CL1 and fractalkine receptor (CX3CR1) expression in abdominal aortic aneurysm disease.
    Patel A; Jagadesham VP; Porter KE; Scott DJ; Carding SR
    Eur J Vasc Endovasc Surg; 2008 Jul; 36(1):20-7. PubMed ID: 18296082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased expression of the fractalkine receptor CX3CR1 on circulating monocytes as new feature of sepsis-induced immunosuppression.
    Pachot A; Cazalis MA; Venet F; Turrel F; Faudot C; Voirin N; Diasparra J; Bourgoin N; Poitevin F; Mougin B; Lepape A; Monneret G
    J Immunol; 2008 May; 180(9):6421-9. PubMed ID: 18424766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine CX3CL1 (fractalkine) and its receptor CX3CR1: occurrence and potential role in osteoarthritis.
    Wojdasiewicz P; Poniatowski LA; Kotela A; Deszczyński J; Kotela I; Szukiewicz D
    Arch Immunol Ther Exp (Warsz); 2014 Oct; 62(5):395-403. PubMed ID: 24556958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
    Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
    PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying a Novel Role for Fractalkine (CX3CL1) in Memory CD8
    Conroy MJ; Maher SG; Melo AM; Doyle SL; Foley E; Reynolds JV; Long A; Lysaght J
    Front Immunol; 2018; 9():1867. PubMed ID: 30150990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fractalkine induces angiogenic potential in CX3CR1-expressing monocytes.
    Park Y; Lee J; Kwak JY; Noh K; Yim E; Kim HK; Kim YJ; Broxmeyer HE; Kim JA
    J Leukoc Biol; 2018 Jan; 103(1):53-66. PubMed ID: 28978662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum level of soluble CX3CL1/fractalkine is elevated in patients with polymyositis and dermatomyositis, which is correlated with disease activity.
    Suzuki F; Kubota T; Miyazaki Y; Ishikawa K; Ebisawa M; Hirohata S; Ogura T; Mizusawa H; Imai T; Miyasaka N; Nanki T
    Arthritis Res Ther; 2012 Mar; 14(2):R48. PubMed ID: 22394569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement.
    Trombetta AC; Soldano S; Contini P; Tomatis V; Ruaro B; Paolino S; Brizzolara R; Montagna P; Sulli A; Pizzorni C; Smith V; Cutolo M
    Respir Res; 2018 Sep; 19(1):186. PubMed ID: 30249259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CX3CR1/CX3CL1 Axis Mediates Platelet-Leukocyte Adhesion to Arterial Endothelium in Younger Patients with a History of Idiopathic Deep Vein Thrombosis.
    Furio E; García-Fuster MJ; Redon J; Marques P; Ortega R; Sanz MJ; Piqueras L
    Thromb Haemost; 2018 Mar; 118(3):562-571. PubMed ID: 29433150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.